Insights on Influenza Vaccine Efficacy in Chronic Kidney Disease from DANFLU Trials

This chapter discusses the findings from the DANFLU-1 trial that compare high and standard dose influenza vaccines in chronic kidney disease patients. It highlights the need for further investigation through clinical outcomes in nationwide registries and expresses hope for advancements in the upcoming DANFLU-2 trial.